Global DNA Sequencing Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2029
Request Covid 19 Impact
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Global DNA Sequencing Market Overview:
“The global DNA Sequencing Market size is expected to be worth around US$ xx Billion by 2021 from US$ X.xx million in 2031, growing at a CAGR of X.x% during the forecast period 2021 to 2031.”
DNA sequencing is the process of determining the nucleic acid sequence – the order of nucleotides in DNA.
It includes any method or technology that is used to determine the order of the four bases: adenine, guanine, cytosine, and thymine.
Numerous advances in bioinformatics and sequencing technology have allowed for the identification of DNA variations as well as in determining variants that are associated with increased risks for diseases.
This has led to the widespread application of Whole-Genome Sequencing (WGS) and Next-Gen Sequencing, thereby, expanding the utility of DNA sequencing in clinical diagnosis applications.
This is a primary factor that is expected to fuel the revenue growth of the global DNA sequencing market over the forecast period.
As DNA sequencing has facilitated a paradigm shift in genomic and proteomic research as it is high-throughput and highly accurate technology, it is being adopted by numerous academic research institutes for research purposes.
This is also a factor that is slated to fuel future market growth opportunities for this global industry.
In light of the recent COVID-19 outbreak, the operations of numerous industries have been either temporarily halted or are functioning with a minimal workforce due to enforced lockdowns and imposed restrictions by respective governing bodies. The global DNA sequencing industry is no different, and this factor is expected to negatively impact the revenue growth of this market in the coming years.
Nonetheless, several initiatives being undertaken by key industry players to boost the clinical utilization of DNA sequencing technologies is another factor that is anticipated to further augment the revenue growth of the global DNA sequencing market in the foreseeable future.
Segmentation of the global DNA sequencing market is as follows:
In terms of product, the consumables segment accounted for the maximum number of revenue shares of the global DNA sequencing market in 2020, and is expected to index a high CAGR over the next decade. This can be attributed to the continual introduction of reagents & kits, as well as the existing wide availability of reagents & kits required to cater to all the processes of library construction. The sequencing services segment is anticipated to index the fastest CAGR over the forecast period.
On the basis of technology, the next-generation sequencing segment accounted for the highest number of revenue shares of the global DNA sequencing market in 2020, and is expected to index considerable revenue growth in the coming years. The third-gen sequencing segment accounted for is also slated to index considerable revenue shares over the next 10 years.
With regards to workflow, the sequencing segment accounted for the maximum number of revenue shares of the global DNA sequencing market in 2020. The data analysis workflow segment is slated to register considerable revenue growth over the forecast period.
Based on application, the oncology segment accounted for the majority number of revenue shares of the global DNA sequencing market in 2020. However, the consumer genomics segment is anticipated to register the fastest CAGR over the next decade.
With respect to end-use, the academic research segment accounted for the highest number of revenue shares of the global DNA sequencing market in 2020, and is expected to register considerable revenue growth in the years to come.
Regional Segmentation and Analysis:
North America accounted for the highest number of revenue shares of the global DNA sequencing market in 2020, and is anticipated to register considerable revenue growth in the years to come. This can be attributed to the presence of well-established healthcare infrastructure, high R&D investments, as well as the incorporation of several technological advancements. The markets in the Asia Pacific region are also slated to index a considerably high CAGR over the forecast period.
Segmentation of the Global DNA Sequencing Market:
Segmentation by Product & Services:
Segmentation by Technology:
- Sanger Sequencing
- Next-Generation Sequencing
- Whole Genome Sequencing (WGS)
- Whole Exome Sequencing (WES)
- Targeted Sequencing & Resequencing
- Third-Generation DNA Sequencing
- Single-Molecule Real-Time Sequencing (SMRT)
- Nanopore Sequencing
Segmentation by Workflow:
- Data Analysis
Segmentation by Application:
- Reproductive Health
- Clinical Investigation
- Agrigenomics & Forensics
- HLA Typing/Immune System Monitoring
- Metagenomics, Epidemiology & Drug Development
- Consumer Genomics
Segmentation by End-Use:
- Academic Research
- Clinical Research
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Other Users
Segmentation by Regions:
- North America
- South America
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- Agilent Technologies Inc.
- Thermo-Fisher Scientific Inc.
- Illumina Inc.
- Hoffmann-La Roche Ltd.
- Oxford Nanopore Technologies Ltd.
- Macrogen Inc.
- Perkin Elmer Inc.
- Pacific Biosciences of California Inc.
- Bio-Rad Laboratories Inc.
- Myriad Genetics Inc.
- PierianDx Inc.
- Intrexon Bioinformatics Germany GmbH (Genomatix GmbH)
- Eurofins Scientific
Request for TOC
Don't just take our word. We are trusted by these great companies!